Skip to content
PubMed This is a summary of 19 peer-reviewed journal articles Updated
Endocrinology

The Long View: Monitoring and Life with ACTH Deficiency

At a Glance

Long-term care for late-onset isolated ACTH deficiency includes checking other pituitary hormones, safe hydrocortisone dosing, bone and metabolic monitoring, and current emergency sick-day plans. Some idiopathic cases recover, but do not change hydrocortisone without medical supervision.

Receiving a diagnosis of late-onset isolated ACTH deficiency (IAD) is not the end of your medical journey, but the start of a new phase of long-term health management. While the condition is currently “isolated,” meaning it only affects your cortisol levels, living with a pituitary disorder requires ongoing vigilance and regular check-ups to ensure your health remains stable [1][2].

The Evolution of “Isolated” Deficiency

The term “isolated” describes your status at the time of diagnosis, but the pituitary gland is a dynamic organ.

  • The Risk of Progression: In some patients, IAD can slowly evolve into multiple pituitary hormone deficiencies (MPHD). Over years, the same process that affected your ACTH production may begin to affect other hormones, such as those controlling your thyroid, growth, or reproductive health [1][2].
  • Possibility of Recovery: Though uncommon, some patients with the “idiopathic” (unknown cause) form of IAD have seen their pituitary gland regain the ability to produce ACTH [1][3]. Recovery is much less common if your condition was caused by cancer immunotherapy [4]. Never stop or reduce hydrocortisone on your own to test your recovery.
  • Monitoring Schedule: To catch these changes early, your endocrinologist will likely recommend an individualized monitoring plan for your other pituitary hormones (such as TSH, Free T4, LH/FSH, and IGF-1) [2][1].
  • Thyroid Warning: If central hypothyroidism is suspected, levothyroxine must never be started until adrenal insufficiency is confirmed to be adequately covered. Thyroid hormone can precipitate an adrenal crisis.

Protecting Your Long-Term Physical Health

Because you will likely be taking hydrocortisone for a long time, monitoring for side effects of “imperfect” dosing is essential. Even small amounts of excess steroid over decades can impact your body [5].

  • Bone Health: Patients on glucocorticoid replacement have a higher risk of osteoporosis and bone fractures [6]. Your doctor may evaluate your fracture risk and order a DEXA scan (a specialized X-ray that measures bone density) according to standard bone-health guidelines to monitor your skeletal health [7][8].
  • Metabolic Health: Steroid use can also affect how your body processes sugar and fat. Regular monitoring of your blood pressure, fasting glucose (or HbA1c), and cholesterol levels is necessary to prevent metabolic syndrome or heart disease [9][10].
  • The Effective Dose Goal: The best way to protect your bones and heart is to work with your doctor to find the appropriate dose of hydrocortisone that keeps your symptoms (like fatigue and nausea) at bay without over-replacing [5][7].

Navigating the Psychological Burden

Living with a condition that requires constant vigilance can take a significant psychological toll. Many patients experience what is sometimes called “adrenal crisis anxiety”—a persistent fear of becoming ill and being unable to access emergency care [11][12].

  • Quality of Life: It is common for patients with adrenal insufficiency to report lower “health-related quality of life,” particularly regarding fatigue and mental health [13][14]. This is a documented medical reality, not a personal failing.
  • The Burden of Vigilance: The need to carry an emergency kit, wear medical jewelry, and “stress dose” during every fever creates a mental load that can lead to burnout [12][11].
  • Strategies for Support: Education is your most powerful tool for reducing anxiety. When you and your loved ones feel confident in using the emergency injection and identifying “sick day” triggers, the fear often becomes more manageable [15][12].

Your Annual Checklist

To stay ahead of potential complications, ensure your follow-up visits cover the following:

  1. Symptom Review: Discuss any persistent fatigue, weight changes, or trouble sleeping [3][16].
  2. Pituitary Labs: Test thyroid and other hormone axes to evaluate if the deficiency remains isolated [2].
  3. Metabolic Screening: Check blood pressure, weight, and blood sugar [17][10].
  4. Emergency Review: Check the expiration date on your emergency injection kit and refresh your “sick day” knowledge [18][19].

By staying proactive with these checks, you can manage the risks of treatment and maintain a high quality of life [5].

Common questions in this guide

Can isolated ACTH deficiency later affect other pituitary hormones?
Yes. In some people, a deficiency that initially affects only ACTH can progress over the years to involve hormones that regulate the thyroid, growth, or reproductive function. An endocrinologist can use individualized follow-up blood tests to look for these changes early.
Can my ACTH production recover after an isolated ACTH deficiency diagnosis?
ACTH production can return in a small number of people with idiopathic isolated ACTH deficiency, but recovery is less common when cancer immunotherapy caused the problem. Do not reduce or stop hydrocortisone to test for recovery; any trial should be planned and supervised by an endocrinologist.
What should regular follow-up visits check for with ACTH deficiency?
Follow-up may include a review of symptoms, blood tests for other pituitary hormones, blood pressure, weight, glucose or HbA1c, cholesterol, and the condition of your emergency injection kit. The timing of each test should be individualized by your healthcare professional.
How can long-term hydrocortisone affect my bones and metabolic health?
Long-term or excessive hydrocortisone replacement can increase the risk of bone loss and fractures and may affect blood pressure, glucose, and cholesterol. Your clinician may assess fracture risk and order a DEXA scan according to bone-health guidelines while adjusting hydrocortisone to an appropriate dose that avoids over-replacement.
Why must adrenal insufficiency be covered before starting thyroid medicine?
Thyroid hormone can worsen inadequately treated adrenal insufficiency and trigger an adrenal crisis. If central hypothyroidism is suspected, your healthcare professional should first confirm that adrenal insufficiency is adequately covered before levothyroxine is started.
How can I manage anxiety about an adrenal crisis?
Learning when to use sick-day dosing, carrying an emergency kit, wearing medical identification, and teaching a trusted person to give the emergency injection can make illness feel more manageable. Ask your healthcare team about local support groups or mental-health resources if fear of adrenal crisis is limiting travel, exercise, or daily activities.

Questions For You

Answer a question to get research tailored to you. Your answers are private.

Get notified when new evidence is published on Late-onset isolated ACTH deficiency.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on the suspected cause of my ACTH deficiency, what are the odds that my pituitary function might recover in the future?
  2. 2.Which other pituitary hormones should we test annually, and are there 'early warning' symptoms I should watch for that suggest the condition is no longer isolated?
  3. 3.Since I am on lifelong steroids, how often should we check my bone density (DEXA scan) and my blood sugar (A1c)?
  4. 4.Are there specific local support groups or psychological resources you recommend for patients managing the stress of chronic adrenal insufficiency?
  5. 5.Is my current hydrocortisone dose the lowest effective amount to manage my symptoms while protecting my bones and heart?

References

References (19)
  1. 1

    Clinical features and autoimmune associations in patients presenting with Idiopathic Isolated ACTH deficiency.

    Hannon AM, Hunter S, Smith D, et al.

    Clinical endocrinology 2018; (88(3)):491-497 doi:10.1111/cen.13536.

    PMID: 29266367
  2. 2

    Hypopituitarism.

    Higham CE, Johannsson G, Shalet SM

    Lancet (London, England) 2016; (388(10058)):2403-2415 doi:10.1016/S0140-6736(16)30053-8.

    PMID: 27041067
  3. 3

    Idiopathic isolated adrenocorticotropic hormone deficiency: a systematic review of a heterogeneous and underreported disease.

    Van Mieghem E, De Block C, De Herdt C

    Pituitary 2024; (27(1)):23-32 doi:10.1007/s11102-023-01366-9.

    PMID: 38151529
  4. 4

    Immunotherapy-induced isolated ACTH deficiency in cancer therapy.

    Iglesias P, Peiró I, Biagetti B, et al.

    Endocrine-related cancer 2021; (28(12)):783-792.

    PMID: 34609950
  5. 5

    SFE/SFEDP adrenal insufficiency French consensus: Introduction and handbook.

    Reznik Y, Barat P, Bertherat J, et al.

    Annales d'endocrinologie 2018; (79(1)):1-22 doi:10.1016/j.ando.2017.12.001.

    PMID: 29338844
  6. 6

    Rate of fracture in patients with glucocorticoid replacement therapy: a systematic review and meta-analysis.

    Li L, Bensing S, Falhammar H

    Endocrine 2021; (74(1)):29-37 doi:10.1007/s12020-021-02723-z.

    PMID: 33846948
  7. 7

    Reduction in daily hydrocortisone dose improves bone health in primary adrenal insufficiency.

    Schulz J, Frey KR, Cooper MS, et al.

    European journal of endocrinology 2016; (174(4)):531-8 doi:10.1530/EJE-15-1096.

    PMID: 26811406
  8. 8

    Effects of Dual-Release Hydrocortisone on Bone Metabolism in Primary and Secondary Adrenal Insufficiency: A 6-Year Study.

    Hasenmajer V, Ferrari D, De Alcubierre D, et al.

    Journal of the Endocrine Society 2023; (8(1)):bvad151 doi:10.1210/jendso/bvad151.

    PMID: 38090230
  9. 9

    Effects of Hydrocortisone on the Regulation of Blood Pressure: Results From a Randomized Controlled Trial.

    Werumeus Buning J, van Faassen M, Brummelman P, et al.

    The Journal of clinical endocrinology and metabolism 2016; (101(10)):3691-3699 doi:10.1210/jc.2016-2216.

    PMID: 27490921
  10. 10

    Glycometabolic Alterations in Secondary Adrenal Insufficiency: Does Replacement Therapy Play a Role?

    Graziadio C, Hasenmajer V, Venneri MA, et al.

    Frontiers in endocrinology 2018; (9()):434 doi:10.3389/fendo.2018.00434.

    PMID: 30123187
  11. 11

    Clinical Unmet Needs in the Treatment of Adrenal Crisis: Importance of the Patient's Perspective.

    Claessen KMJA, Andela CD, Biermasz NR, Pereira AM

    Frontiers in endocrinology 2021; (12()):701365 doi:10.3389/fendo.2021.701365.

    PMID: 34354671
  12. 12

    Factors influencing self-management of adrenal crisis in patients with adrenal insufficiency: a qualitative study.

    Chua A, Yoeli H, Till D, et al.

    Endocrine connections 2025; (14(5)).

    PMID: 40214077
  13. 13

    Determinants of Quality of Life in Patients with Immune-Checkpoint-Inhibitor Induced Secondary Adrenal Insufficiency.

    Herndon J, Hleibiehova Y, Achenbach SJ, et al.

    The Journal of clinical endocrinology and metabolism 2026; doi:10.1210/clinem/dgag219.

    PMID: 42212516
  14. 14

    Group 1. Epidemiology of primary and secondary adrenal insufficiency: Prevalence and incidence, acute adrenal insufficiency, long-term morbidity and mortality.

    Chabre O, Goichot B, Zenaty D, Bertherat J

    Annales d'endocrinologie 2017; (78(6)):490-494 doi:10.1016/j.ando.2017.10.010.

    PMID: 29174931
  15. 15

    The incidence of adrenal crisis in the postoperative period of HPA axis insufficiency after surgical treatment for Cushing's syndrome.

    Broersen LHA, van Haalen FM, Kienitz T, et al.

    European journal of endocrinology 2019; (181(2)):201-210.

    PMID: 31167165
  16. 16

    Usage of continuous glucose monitoring (CGM) for detecting an unrecognized hypoglycemia and management of glucocorticoid replacement therapy in adult patients with central hypoadrenalism.

    Watanabe T, Ozawa A, Ishii S, et al.

    Endocrine journal 2018; (65(5)):547-556 doi:10.1507/endocrj.EJ16-0387.

    PMID: 29618670
  17. 17

    Primary hypothyroidism and isolated ACTH deficiency induced by nivolumab therapy: Case report and review.

    Zeng MF, Chen LL, Ye HY, et al.

    Medicine 2017; (96(44)):e8426 doi:10.1097/MD.0000000000008426.

    PMID: 29095280
  18. 18

    [Emergency card, emergency medication, and information leaflet for the prevention and treatment of adrenal crisis (Addison crisis): an Austrian consensus document].

    Pilz S, Krebs M, Bonfig W, et al.

    Journal fur klinische Endokrinologie und Stoffwechsel 2022; (15(1)):5-27 doi:10.1007/s41969-022-00155-2.

    PMID: 35251520
  19. 19

    Adrenal Insufficiency in Adults: A Review.

    Vaidya A, Findling J, Bancos I

    JAMA 2025; (334(8)):714-725 doi:10.1001/jama.2025.5485.

    PMID: 40522647

This page is for informational purposes only and does not constitute medical advice. Your endocrinologist should tailor hydrocortisone dosing, hormone testing, emergency planning, and bone or metabolic screening to your needs.